Cargando…
Anticancer agents : frontiers in cancer chemotherapy /
| Autores Corporativos: | , , |
|---|---|
| Otros Autores: | , , |
| Formato: | Libro |
| Lenguaje: | English |
| Publicado: |
Washington, DC :
American Chemical Society,
c2001.
|
| Colección: | ACS symposium series;
796 |
| Materias: |
Tabla de Contenidos:
- Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville ... [et al.]
- Evolutionary biosynthesis of anticancer drugs / George R. Pettit
- Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow ... [et al.]
- New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima ... [et al.]
- Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz ... [et al.]
- Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite ... [et al.]
- Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann ... [et al.]
- Synthesis and biological activity of epothilones / Ulrich Klar ... [et al.]
- Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou
- Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih ... [et al.]
- Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs ... [et al.]
- Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt
- Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras ... [et al.]
- Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.]
- STI571 : a new treatment modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger
- The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana
- Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley
- Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky
- Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari.